Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

626
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
626
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

632
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
632
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spiritual care for Latinx youth with type 1 diabetes (T1D) and their caregivers: qualitative analysis of focus groups.

Diabetology & metabolic syndrome·2026
Same author

Ventricular conduction is a marker for arrhythmic risk in SCN5A-E1784K overlap sodium channel disease.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026
Same author

Considerations on phrenic nerve and sinus node safety during superior vena cava isolation using a balloon-in-basket pulsed field ablation system.

Heart rhythm O2·2026
Same author

Integrated mapping-guided superior vena cava isolation with single-shot pulsed field ablation systems: Feasibility, workflow, and safety in a real-world patient cohort.

Heart rhythm·2026
Same author

Regression of massive left ventricular hypertrophy in Danon disease.

Acta cardiologica·2026
Same author

Initial Clinical Experience With a Novel 4D Intracardiac Echocardiographic Imaging and Guidance System in Catheter Ablation Procedures.

Journal of cardiovascular electrophysiology·2026
Same journal

The ethical application of artificial intelligence in digital health: patients' knowledge, pulmonary hypertension, and the problem of misrecognition.

European heart journal. Digital health·2026
Same journal

Deep learning analysis of single-lead electrocardiograms enables pragmatic heart failure risk assessment in the general population.

European heart journal. Digital health·2026
Same journal

Artificial stupidity or logimorphism? How misuse of language warps our thinking about 'artificial intelligence'.

European heart journal. Digital health·2026
Same journal

Editorial: listening for congestion in heart failure.

European heart journal. Digital health·2026
Same journal

A pilot study on AI-based voice analysis for monitoring patients hospitalized with acute decompensated heart failure.

European heart journal. Digital health·2026
Same journal

Towards a reliable and fully automated analysis of computed tomography coronary angiography: an unmet need.

European heart journal. Digital health·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K

Streamlining atrial fibrillation ablation management using a digitization solution.

Jim O'Brien1, Sergio Valsecchi2, Fionnuala Seaver1

  • 1Atrial Fibrillation Institute, Mater Private Hospital, 71 Eccles Street, Dublin 7, D07 T92C, Ireland.

European Heart Journal. Digital Health
|July 31, 2024
PubMed
Summary
This summary is machine-generated.

A new mobile app and treatment pathway improved patient education and adherence for atrial fibrillation (AF) catheter ablation. This patient-centered approach enhances understanding of AF management and treatment complications.

Keywords:
Atrial fibrillationCare digitalizationCatheter ablationKnowledgeOutpatient carePatient educationPatient engagement

More Related Videos

Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.6K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.3K

Related Experiment Videos

Last Updated: May 3, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

33.4K
Robotic Ablation of Atrial Fibrillation
11:21

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

19.6K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology
10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

13.3K

Area of Science:

  • Cardiology
  • Digital Health
  • Patient Education

Background:

  • Catheter ablation is a standard treatment for atrial fibrillation (AF).
  • Effective patient education on procedure efficacy, complications, stroke risk, and anticoagulation is vital.
  • Optimizing patient management for AF catheter ablation requires addressing knowledge gaps and improving adherence.

Purpose of the Study:

  • To implement and evaluate a patient-centered solution integrating a customized treatment pathway and mobile application for AF catheter ablation candidates.
  • To enhance clinical management by improving patient knowledge and adherence to guideline-based care.

Main Methods:

  • A mobile application and customized treatment pathway were implemented at Mater Private Hospital.
  • The solution automated pre-operative assessments and post-operative support, facilitating patient-clinician communication.
  • Patient engagement and adherence to the pathway were tracked from September 2022 to April 2023.

Main Results:

  • 63 patients installed the app, with 98% engaging in the treatment pathway and 81% completing pre-operative tasks.
  • The average enrolment-to-admission time was 14 days; 62% completed post-ablation tasks within 36 days.
  • High patient satisfaction and improved knowledge of AF, symptoms, and anticoagulation complications were reported.

Conclusions:

  • The app-based Ablation Solution demonstrated successful implementation with high patient utilization and adherence.
  • The system effectively improved patient understanding of AF and its treatments.
  • This approach offers a promising method for streamlining AF catheter ablation management and enhancing patient outcomes.